Items Tagged ‘Acute Myeloid Leukemia’

July 23, 2018

Tibsovo Approved for Treatment of Relapsed/Refractory Acute Myeloid Leukemia and an IGH1 Mutation

By

Tibsovo® (ivosidenib) has been granted approval from the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (R/R AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA approved test. Data leading to the FDA approval was from a trial that included […]

View full entry

Tags: Acute Myeloid Leukemia, IGH1 Mutation, Leukemia, News, refractory, relapsed, Tibsovo, treatment


January 31, 2018

U.S. FDA Approves Trisenox® Injection for First Line Treatment of Acute Promyelocytic Leukemia

By

CancerConnect News: the U.S. Food and Drug Administration (FDA) has approved the use of Trisenox® (arsenic trioxide) injection in combination with tretinoin for the treatment of adults with newly-diagnosed low-risk acute promyelocytic leukemia (APL) whose APL is characterized by the presence of the (15;17) translocation or PML/RAR-alpha gene expression. The approval was based on a Priority Review by […]

View full entry

Tags: Acute Myeloid Leukemia, Leukemia, News


September 5, 2017

FDA Approves Mylotarg for Treatment of Acute Myeloid Leukemia

By

The U.S. Food and Drug Administration today approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid leukemia whose tumors express the CD33 antigen (CD33-positive AML). The FDA also approved Mylotarg for the treatment of patients aged 2 years and older with CD33-positive AML who have experienced a relapse or who […]

View full entry

Tags: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, AML, CD33 antigen, gemtuzumab ozogamicin, Leukemia, Mylotarg, News, Precision Cancer Medicine, targeted therapy


March 20, 2009

Life's Lessons Learned Early

By

By Diana Price When Pia Awal went to the emergency room in June 2002 after suffering from a fever that antibiotics couldn’t wipe out and bone pain that was getting increasingly worse, the last thing she expected to hear was a cancer diagnosis. And when the doctors delivered the news that her symptoms were the […]

View full entry

Tags: Acute Myeloid Leukemia


September 29, 2008

Survival Rates Improving in Childhood Hematologic Cancers

By

Survival Rates Improving in Childhood Hematologic Cancers Five- and 10-year survival rates in childhood hematalogic cancers have significantly improved since 1990, according to the results of a study recently published in the Journal of the National Cancer Institute. Approximately 40% of childhood cancers are classified as hematalogic cancers. Hematologic cancers are cancers of the blood […]

View full entry

Tags: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Advanced Stage Hodgkin's Lymphoma, Aggressive/Intermediate Grade Non-Hodgkin's Lymphoma, Early Stage Hodgkin's Lymphoma, Highly Aggressive/High Grade Non-Hodgkin's Lymphoma, Indolent/Low Grade Non-Hodgkin's Lymphoma


August 12, 2008

Injection of Umbilical Cord Stem Cells into Bone Appears Promising for Leukemia

By

Injection of Umbilical Cord Stem Cells into Bone Appears Promising for Leukemia The injection of stem cells collected from umbilical cords into the pelvic bone of patients with leukemia appears promising; however, longer follow-up is necessary to determine outcomes for these patients. These results were recently published in an early online publication of the Lancet […]

View full entry

Tags: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Allogeneic Stem Cell Transplant


July 28, 2008

Prophylactic Use of Specific Antibiotics Reduce the Risk of Some Infections in AML

By

Prophylactic Use of Specific Antibiotics Reduce the Risk of Some Infections in AML Specific antibiotics used during remission (no evidence of disease) following induction therapy reduce the risk of some types of infection and associated complications among pediatric patients with acute myeloid leukemia. These results were published in an early on-line version?in the journal Cancer. […]

View full entry

Tags: Acute Myeloid Leukemia